We propose that effector CD4+ T cells, which are largely regulated by Foxp3+ Tregs during tumor formation, are capable of maintaining immune control against FBL-3 tumor via direct killing and can functionally replace CD8+ T cells. This evidence concerns the gene FOXP3 and neoplasm.